Stakeholder Perspectives on the Design of First-In-Human Trials for Artificial Amnion and Placenta Technology: A Qualitative Study

BJOG: An International Journal of Obstetrics & Gynaecology Pub Date : 2025-04-29 DOI:10.1111/1471-0528.18189

Angret de Boer, André Krom, Rania Kalaai, Marieke de Vries, Marije Hogeveen, Sylvia A. Obermann-Borst, Marijn Vermeulen, M. Beatrijs van der Hout-van der Jagt, Juliette S. van Haren, Peter Andriessen, Martine C. de Vries, Rosa Geurtzen, E. J. T. Verweij

引用次数: 0

Abstract

Artificial Amnion and Placenta Technology (AAPT), designed to improve outcomes in extreme prematurity, has shown promise in animal studies, with human trials anticipated soon. This study seeks to inform the responsible design of future trials by utilising insights from parents who experienced an (imminent) extremely premature birth and perinatal healthcare professionals (HCPs).

查看原文本刊更多论文

利益相关者对人工羊膜和胎盘技术首次人体试验设计的看法：一项定性研究

人工羊膜和胎盘技术（AAPT）旨在改善极端早产的结果，在动物研究中显示出希望，预计很快将进行人体试验。本研究旨在通过利用来自经历（即将）极度早产的父母和围产期保健专业人员（HCPs）的见解，为未来试验的负责任设计提供信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BJOG: An International Journal of Obstetrics & Gynaecology

自引率

0.00%

发文量